2: Ascertainment

No. of Cases (current year) and percentage change vs. previous year (persons)

	UKIACR average (population)	UKIACR average (country)	England	Scotland	Wales	Northern Ireland	Republic of Ireland
All invasive xnmsc	380,964 (1%)	0.4%	299969 (1.3%)	31277 (-1.9%)	19004 (-1.7%)	9256 (1.6%)	21458 (2.4%)
All xnmsc 0-24	4,336 (3.3%)	2.9%	3417 (3.6%)	310 (6.7%)	205 (4.8%)	118 (5%)	286 (-5.5%)
All xnmsc 25-59	90,238 (1.8%)	0.6%	70178 (2.4%)	7346 (-2%)	4003 (-0.6%)	2364 (0.8%)	6347 (2.5%)
All xnmsc 60-79	203,814 (1.6%)	0.6%	159767 (2.1%)	17103 (-1.9%)	10521 (-2%)	4945 (1.8%)	11478 (2.8%)
All xnmsc 80+	82,576 (-1.5%)	-0.5%	66607 (-1.6%)	6518 (-2.3%)	4275 (-2.2%)	1829 (1.9%)	3347 (1.7%)
All registrations	632,493 (2.7%)	1.0%	493618 (3.4%)	52385 (-0.5%)	28808 (-1.7%)	17248 (0.4%)	40434 (3.6%)
Haematology	33,437 (1.3%)	2.0%	26871 (1.2%)	2371 (0.3%)	1704 (4%)	775 (3.7%)	1716 (0.8%)
Head and Neck	12,752 (5%)	5.9%	9733 (5.4%)	1280 (-0.6%)	685 (4.3%)	362 (12.2%)	692 (8.4%)
Lower GI	47,669 (0.3%)	-2.6%	37324 (1.2%)	3928 (-4%)	2408 (-5.9%)	1189 (-9%)	2820 (4.7%)
Upper GI	16,947 (0.4%)	-1.2%	13110 (1.1%)	1526 (-6.6%)	895 (0.9%)	404 (-7%)	1012 (5.7%)
HPB	18,816 (3.1%)	3.9%	14748 (3.1%)	1620 (1.8%)	968 (3.9%)	491 (9.5%)	989 (1.4%)
Trachea, Bronchus & Lung	48,723 (-0.6%)	-1.4%	37641 (0.3%)	4968 (-7.2%)	2448 (-0.7%)	1240 (0.8%)	2426 (-0.5%)
Melanoma	17,071 (8.9%)	9.9%	13356 (8.4%)	1358 (12.6%)	784 (0.5%)	402 (11.6%)	1171 (16.5%)
Breast	58,476 (2.8%)	4.5%	46100 (2.5%)	4753 (1.8%)	2836 (1%)	1468 (11.4%)	3319 (5.8%)
Cervix	3,366 (-3.3%)	-5.9%	2521 (-3.3%)	379 (12.6%)	150 (-10%)	81 (-13.5%)	235 (-15.4%)
Other Female Genitals	18,946 (-1.5%)	-2.1%	14940 (-1.2%)	1574 (-1%)	948 (-10.3%)	506 (0%)	978 (1.8%)
Prostate	50,239 (0.1%)	-1.5%	40310 (1.1%)	3052 (-6.2%)	2567 (-0.9%)	1133 (4.4%)	3177 (-5.9%)
Kidney	12,759 (2.9%)	-0.7%	10333 (4.3%)	924 (0.2%)	547 (-8.5%)	339 (6.7%)	616 (-6.3%)
Bladder	10,582 (-3%)	1.0%	8499 (-4%)	822 (-1.6%)	554 (-4.9%)	213 (1.9%)	494 (13.4%)
Brain and CNS	5,858 (1.2%)	-4.2%	4652 (3.2%)	412 (-9.2%)	278 (-4.9%)	137 (-8.5%)	379 (-1.6%)
Thyroid & other endocrine glands	4,138 (5.5%)	-2.4%	3343 (8.2%)	300 (4.9%)	125 (-10.7%)	87 (-4.4%)	283 (-10.2%)
CUP	9,132 (-5.3%)	-1.8%	7104 (-7%)	865 (0%)	524 (-4.6%)	163 (-19.3%)	476 (22.1%)
Other invasive cancer	12,053 (-2.4%)	-1.2%	9384 (-3.1%)	1145 (-1.1%)	583 (-6.4%)	266 (-7.1%)	675 (11.4%)
Breast in situ	8,342 (9.4%)	14.2%	6852 (9.6%)	466 (4.6%)	336 (-7%)	237 (54.9%)	451 (8.8%)
Cervix in situ	33,608 (-1.7%)	-2.6%	25034 (-1.5%)	2542 (-3%)	1734 (-15.4%)	1145 (-0.4%)	3153 (7.1%)
Other tumours	53,714 (-0.3%)	-0.8%	36536 (0.1%)	6236 (-3.4%)	3333 (7%)	2780 (-10.3%)	4829 (2.6%)
Other non-melanoma skin cancer	2371 (4.4%)	8.2%	1460 (-2.2%)	178 (18.9%)	481 (57.4%)	61 (-66%)	191 (32.9%)
Basal cell carcinoma	116078 (8.6%)	3.6%	95562 (9.8%)	8474 (5.6%)	2145 (-10.6%)	2715 (7.9%)	7182 (5.1%)
Squamous cell carcinoma	37500 (11.4%)	7.1%	28205 (13.4%)	3296 (8.1%)	1775 (2.1%)	1054 (7.6%)	3170 (4.3%)

National Cancer Registry Ireland

Error message

No. of Cases (current year) and percentage change vs. previous year (persons)